Boehringer buying Amgen site to expand biologics CMO biz
Boehringer Ingelheim is to acquire a California, US manufacturing facility from Amgen to expand its contract biologics production capabilities.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs